Raising $1M Pre-Series A Round for Customer Development & Pilot Launch
100 M stroke survivors globalally needing hand rehabilitation.
Current Standard-of-Care focusses on balance, gait and Speech
No effective Intervention for Hand = Life Long disability.
Costs ~$46 billion/Year to the US Economy
The MyHandTM System
Digital Neuro-Rehab Platform for Home or Clinic use
Large and poorly met market.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
With a mission to help 100 million stroke survivors living with hand function disability from acquired brain injury, IRegained has developed the MyHand™ System – a neuroplasticity enhancing, research-driven, telemedicine-powered, clinically effective and affordable hand function rehabilitation system.
Key Highlights
Healthcare, science and engineering, technology, platforms, therapy, telehealth, software, medical devices, rehabilitation, stroke/neuroplasticity, telemedicine
Phase I: Rehabilitation Hospitals, Clinics, Nursing Homes, Skilled Nursing Facilities (SNFs), Long-term Care Centers and Individual PTs/OTs
Phase II: Home Healthcare Agencies and Individual Stroke Patients for Home-Use
TAKE YOUR REHABILITATION TO NEW HEIGHTS
In most cases (70%), the brain damage from stroke results in impaired hand function. This makes mundane tasks, such as holding a cup, combing hair or toileting -- which able-bodied people take for granted -- almost impossible to do.
Stroke survivors unfortunately have to live with this disability for rest of their lives, depending on personal support workers and caregivers.
Not only does this lead to a very poor overall quality of life for the patient, but also costs the US healthcare system $34 billion annually, not to mention, the lost workdays and negative impact on economic output.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Recovering hand function requires targeted neuro-rehabilitation therapy with intensity and repetition for months and potentially years (10-20 sessions per week).
Furthermore, there are very few clinically validated hand-function rehabilitation devices in the market.
Those that exist are either ineffective (ex: squeeze balls, rubber bands, etc.) because they do not leverage neuroplasticity to recover the brain’s ability to control the hand, or cost prohibitive (e.g. robotic devices >$150,000) and therefore unaffordable.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
The system leverages neuroplasticity, the human brain’s ability to ‘reprogram’ its neural pathways. Backed by 40 years of clinical and scientific research-based evidence and with guidance from accomplished rehab professionals, this system can help people with hand-function disability regain their independence.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
The MyHand System is:
Intelligent
Smart device built on proven clinical protocols for targeted hand therapy.
Connected
IoMT-based internet-connected device with built-in IRegained app store to access engaging hand-rehab games.
Neuroplastic
Intelligent algorithms developed through deep scientific research on leveraging neuroplasticity and applying it for motor control recovery.
Built for Tele-Rehab
Integral telemedicine platform for remote rehabilitation in the comfort of patient’s home – particularly critical in COVID-19 Pandemic.
Effective
Proven clinical efficacy in recovery of hand function.
Affordable
Affordable system with attractive financing and leasing options.
Ready for home use
One of the very few rehabilitation systems than can be effectively used in the comfort of home.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
We offer a compelling value proposition for customers across both B2B and B2C. There is 4-5 month pay back period and strong ROI for clinics and long term-care institutions.
Further, COVID-19 has ignited the telemedicine market, and IRegained's MyHand™ System was designed with telemedicine in mind.
Our offering has a low risk regulatory classification (class 1 classification = faster time to market) with pending patents in US, EU, Canada, China and India (Strong IP = higher competitive barrier).
TAKE YOUR REHABILITATION TO NEW HEIGHTS
TAKE YOUR REHABILITATION TO NEW HEIGHTS
ACHIEVED SIGNIFICANT MILESTONES DESPITE COVID 19 CHALLENGES
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Octane Launchpad Alumni, Irvine, CA, USA -- Accelerator
SoCal Bio, CA, USA – Incubator
Canadian Technology Accelerator (CTA Graduate) – Accelerator Program
University City Science Center & Launch Lane Accelerator, Philadelphia, PA, USA – Accelerator
Ionic Mechatronics, Sudbury, ON, Canada – Hardware Development Partner
Synaptic Technologies, Sudbury, ON, Canada – Software Development Partner
NORCAT, Sudbury, ON, Canada -- Incubator
Foundry, Innovation Centre at Laurentian University, Sudbury, ON, Canada - Incubator
Laurentian University, Sudbury, ON, Canada – Academic Research Partner
Cambrian College, Sudbury, ON, Canada -– Academic Research Partner
Health Sciences North and HSNRI, Sudbury, ON, Canada – Clinical Research Partner
Baycrest Hospital, Toronto, ON, Canada
McMaster University, Sudbury, ON, Canada - – Clinical Research Partner
Sunnybrook Hospital, Toronto, ON, Canada -- – Clinical Research Partner
Sheba Medical Center, Tel Aviv, Israel - – Clinical Research Partner
University of Texas, San Antonio, Texas, USA - – Clinical Research Partner
Christian Medical College & Hospital (CMC&H), Vellore, TN, India - Academic & Clinical Research Partner
Cerner India Pvt. Ltd., Bangalore, India – Advanced Technology Development + R&D Partner
OUR ADVISOR
Dr. Jocelyn Harris (Chair, CAB)
Associate Professor, McMaster University
Dr. Julie Vaughan Graham
Physical Therapist, Adjunct Lecturer, University of Toronto.
Dr. Yafi Levanon
Occupational Therapist, Tel Aviv University, Sheba Medical Centre, Israel
Dr. Jed Meltzer
Neuroscientist, Baycrest Hospital, University of Toronto
Dr. Shoba Moses
Clinical Occupational Therapist, Dallas, USA
Dr. Michael Franklyn
Prof. Northern Ontario School of Medicine
Peter Dal Bianco
Sudbury, ON Canada
Neelima Firth
Thousand Oaks, CA, USA
David Hood
Long Beach, CA, USA
Rav Sheth
Boston, MA USA
Chad Pallopson
Toronto, ON Canada
Dr. Dennis Reich
Sudbury, ON Canada
BE A PART OF THIS AMAZING JOURNEY
We have a convertible debenture round open till March 31st 2022 with additional incentives to early investors . Learn more
For this round, IRegained is seeking a total raise of CAD $1,000,000 with CAD $510,000 secured to-date CAD $350,000 in soft-circled commitments secured to-date.
The funds will allow us to reach the following milestones:
Complete product development and launch our pre-commercial (alpha) prototypes in key clinical test sites (~20 across US and Canada)
Gather additional independent clinical data to support payor reimbursement & customer adoption
Gather additional independent clinical data to support payor reimbursement & customer adoption
TAKE YOUR REHABILITATION TO NEW HEIGHTS
IRegained is on a mission to help 100 million stroke survivors regain their hand function.
We are strategically poised to serve a large, poorly met market that has yet to find the solution they needed by stroke patients to live a healthier, more functional life.
We have achieved significant milestones, despite odds and challenges from COVID-19.
And with your financial support, we can do so much more.
For more information on this investment opportunity, please contact:
Vineet Johnson, CEO
Standing united in our dreams to help stroke patients reclaim their lives.
IRegained is a MedTech company developing novel solutions for the physical rehabilitation needs of people with disability. With a mission to help 100 million stroke survivors with hand function disability from brain injury, IRegained has developed the MyHandTM System.
NORCAT, 1545 Maley Drive, Sudbury, ON, P3A 4R7
Unit #1, 764 Notre Dame Avenue, Sudbury, ON P3A 2T4
